These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 6315221)
1. Role of plasminogen activator in the morphological alterations induced by derivatives of adenosine cyclic 3':5'-monophosphate in hepatoma tissue culture cells. Barouski-Miller PA; Gelehrter TD Cancer Res; 1983 Dec; 43(12 Pt 1):5922-30. PubMed ID: 6315221 [TBL] [Abstract][Full Text] [Related]
2. Hormonal regulation of plasminogen activator in rat hepatoma cells. Gelehrter TD; Barouski-Miller PA; Coleman PL; Cwikel BJ Mol Cell Biochem; 1983; 53-54(1-2):11-21. PubMed ID: 6312282 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides. Heaton JH; Kathju S; Gelehrter TD Mol Endocrinol; 1992 Jan; 6(1):53-60. PubMed ID: 1738371 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera. Hargrove JL; Granner DK J Cell Physiol; 1982 Jun; 111(3):232-8. PubMed ID: 6124549 [TBL] [Abstract][Full Text] [Related]
5. The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor. Tranquille N; Emeis JJ Thromb Haemost; 1993 Mar; 69(3):259-61. PubMed ID: 8097063 [TBL] [Abstract][Full Text] [Related]
6. Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cells. Barouski-Miller PA; Gelehrter TD Proc Natl Acad Sci U S A; 1982 Apr; 79(7):2319-22. PubMed ID: 6179095 [TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells. Heaton JH; Gelehrter TD Mol Endocrinol; 1990 Jan; 4(1):171-8. PubMed ID: 2157975 [TBL] [Abstract][Full Text] [Related]
8. Comparative studies of heat sensitivity of several rat hepatoma cell lines and hepatocytes in primary culture. Schamhart DH; Berendsen W; van Rijn J; van Wijk R Cancer Res; 1984 Oct; 44(10):4507-16. PubMed ID: 6467209 [TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Rose RJ; Liu H; Palmer D; Maurice DH Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930 [TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured monkey Sertoli cells. Liu YX; Liu K; Zhou HM; Du Q; Hu ZY; Zou RJ Hum Reprod; 1995 Mar; 10(3):719-27. PubMed ID: 7540182 [TBL] [Abstract][Full Text] [Related]
11. Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity. Mediation by glucocorticoid receptors. Barouski-Miller PA; Gelehrter TD J Steroid Biochem; 1984 Feb; 20(2):533-7. PubMed ID: 6142981 [TBL] [Abstract][Full Text] [Related]
12. Effects of 8-bromoadenosine 3':5'-cyclic monophosphate on proteolytic enzymes, adhesiveness and lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells. Takenaga K Jpn J Cancer Res; 1986 Oct; 77(10):998-1004. PubMed ID: 3023266 [TBL] [Abstract][Full Text] [Related]
13. The influence of culture conditions on the induction of tyrosine aminotransferase by cyclic nucleotides in rat hepatoma cells. Stellwagen RH; Kohli KK; Sailor RD J Cell Physiol; 1977 Apr; 91(1):51-61. PubMed ID: 16019 [TBL] [Abstract][Full Text] [Related]
14. Isolation of rat hepatoma cell variants selectively resistant to dexamethasone inhibition of plasminogen activator. Seifert SC; Gelehrter TD J Cell Physiol; 1979 Jun; 99(3):333-41. PubMed ID: 457795 [TBL] [Abstract][Full Text] [Related]
15. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate. Wilson MJ; Ludowese C; Sinha AA; Estensen RD Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400 [TBL] [Abstract][Full Text] [Related]
16. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. Imai T; Hirata Y; Kanno K; Marumo F J Clin Invest; 1994 Feb; 93(2):543-9. PubMed ID: 7509342 [TBL] [Abstract][Full Text] [Related]
17. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
18. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964 [TBL] [Abstract][Full Text] [Related]
19. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Aharoni D; Dantes A; Oren M; Amsterdam A Exp Cell Res; 1995 May; 218(1):271-82. PubMed ID: 7537693 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]